Do you offer adjuvant therapy for high grade upper tract urothelial carcinoma?

Phase III POUT trial supports adjuvant chemotherapy in certain high risk patients with upper urinary tract urothelial cancer. How does CKD and/or being dialysis-dependent influence your decision? How do you decide between platinum-based chemotherapy and immunotherapy?